Evoke plc (LON:EVOK – Get Free Report)’s share price fell 10% during mid-day trading on Friday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
Several brokerages have commented on EVOK. Berenberg Bank lowered their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th.
View Our Latest Stock Analysis on EVOK
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling at Evoke
In related news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 03/24 – 03/28
- Short Selling – The Pros and Cons
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How Technical Indicators Can Help You Find Oversold Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.